Free Trial
NASDAQ:GEHC

GE HealthCare Technologies Q3 2026 Earnings Report

GE HealthCare Technologies logo
$63.89 -0.78 (-1.20%)
As of 01:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.

GE HealthCare Technologies EPS Results

Actual EPS
N/A
Consensus EPS
$1.21
Beat/Miss
N/A
One Year Ago EPS
N/A

GE HealthCare Technologies Revenue Results

Actual Revenue
N/A
Expected Revenue
$5.35 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

GE HealthCare Technologies Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
Wednesday, October 28, 2026
Conference Call Time
8:30AM ET

Conference Call Resources

GE HealthCare Technologies Earnings Headlines

Barclays Upgrades GE HealthCare Technologies (NASDAQ:GEHC) to Strong-Buy
Inside a Former Merrill Lynch Advisor's Income Playbook
A former Merrill Lynch and Vanguard advisor spent 25 years watching one weekly options play generate consistent income in bull, bear, and sideways markets alike. Now he's sharing it in a free guide called the Rapid Retirement Guide, breaking down the four principles behind every trade and the technique institutional desks have quietly used for decades.tc pixel
See More GE HealthCare Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GE HealthCare Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GE HealthCare Technologies and other key companies, straight to your email.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ:GEHC) is a global medical technology and healthcare services company that develops, manufactures and supports products used by hospitals, clinicians and researchers. Its offerings are designed to assist with disease detection, diagnosis, treatment, patient monitoring and clinical workflow management.

The company’s portfolio includes computed tomography, magnetic resonance imaging, X-ray and molecular imaging systems; ultrasound equipment; patient monitoring and anesthesia delivery technologies; and pharmaceutical diagnostics, including contrast agents used in medical imaging. GE HealthCare also provides software, digital solutions, equipment maintenance and other services intended to help healthcare providers improve operational and clinical decision-making.

GE HealthCare became an independent publicly traded company in January 2023 following its separation from General Electric. The company serves healthcare providers and related organizations in markets around the world. GE HealthCare is led by President and Chief Executive Officer Peter Arduini.

View GE HealthCare Technologies Profile